Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated

Clinical Infectious Diseases

Volumn 65, Issue 2, 2017, Pages 226-232

  Wendorf, Kristen A ^a   Winter, Kathleen ^a   Zipprich, Jennifer ^a   Schechter, Rob ^a   Hacker, Jill K ^b   Preas, Chris ^b   Cherry, James D ^c   Glaser, Carol ^d   Harriman, Kathleen ^a  

^a Immunization Branch   (United States)

^b Viral and Rickettsial Disease Laboratory   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

measles.; SSPE; subacute sclerosing panencephalitis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; HYPERACTIVITY; INFANT; LETHARGY; MALE; MEASLES; MEASLES VACCINATION; MEDICAL HISTORY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROBLEM BEHAVIOR; RASH; SEIZURE; SEROLOGY; SUBACUTE SCLEROSING PANENCEPHALITIS; ADOLESCENT; ADULT; CALIFORNIA; CASE REPORT; CEREBROSPINAL FLUID; COMPLICATION; IMMUNOLOGY; INCIDENCE; MEASLES VIRUS; PRESCHOOL CHILD; RISK FACTOR; SEX FACTOR; VACCINATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CALIFORNIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RISK FACTORS; SEX FACTORS; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION; YOUNG ADULT;

EID: 85023169071     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix302     Document Type: Article

References (23)

1. Cherry JD. Measles virus. In: Cherry JD, eds. Feigin and Cherry's textbook of pediatric infectious diseases. 7th ed. Vol 2 Philadelphia, PA: Elsevier, 2014:2373-95
2. Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005; 192:1686-93
3. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007; 36:1334-48
4. Miller C, Andrews N, Rush M, Munro H, Miller E. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 2004; 89:1145-8
5. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992; 21:998-1006
6. Schonberger K, Ludwig MS, Wildner M, Weissbrich B. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One 2013; 8:e68909
7. Centers for Disease Control and Prevention. Measles: for travelers. Available at: http://www.cdc.gov/measles/travelers.html. Accessed 6 December 2016
8. Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Measles outbreak-California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep 2015; 64:153-4
9. Centers for Disease Control and Prevention. Subacute sclerosing panencephalitis surveillance-United States. MMWR Morb Mortal Wkly Rep 1982; 31:585-8
10. Cremer NE, Cossen CK, Shell G, Diggs J, Gallo D, Schmidt NJ. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol 1985; 21:869-74
11. Honarmand S, Glaser CA, Chow E, et al. Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology 2004; 63:1489-93
12. Park SY, Kohl S. Subacute sclerosing panencephalitis in an identical twin. Pediatrics 1999; 104:1390-4
13. Reis GF, Ritter JM, Bellini WJ, Rota PA, Bollen AW. A 29-year-old pregnant woman with worsening left hemiparesis, encephalopathy, and hemodynamic instability: a case report of subacute sclerosing panencephalitis. Clin Neuropathol 2015; 34:258-66
14. Centers for Disease Control and Prevention. Measles-United States, January 1-August 24, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:741-3
15. Darmstadt GL, Halsey NA. Measles in mother-infant pairs. Pediatr Infect Dis J 1992; 11:492-3
16. Chiu MH, Meatherall B, Nikolic A, et al. Subacute sclerosing panencephalitis in pregnancy. Lancet Infect Dis 2016; 16:366-75
17. Centers for Disease Control and Prevention. Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children-United States, 1989-1991. MMWR Morb Mortal Wkly Rep, 1992; 41:522-5
18. Dales LG, Kizer KW, Rutherford GW, Pertowski CA, Waterman SH, Woodford G. Measles epidemic from failure to immunize. West J Med 1993; 159:455-64
19. Gindler JS, Atkinson WL, Markowitz LE, Hutchins SS. Epidemiology of measles in the United States in 1989 and 1990. Pediatr Infect Dis J 1992; 11:841-6
20. Davis SF, Strebel PM, Atkinson WL, et al. Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health 1993; 83:1011-5
21. Ewert DP, Frederick PD, Run GHF, Mascola L. The reporting efficiency of measles by hospitals in Los Angeles County, 1986 and 1989. Am J Public Health 1994; 84:868-9
22. Ewert DP, Westman S, Frederick PD, Waterman SH. Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles. Public Health Rep 1995; 110:161-5
23. Harpaz R. Completeness of measles case reporting: review of estimates for the United States. J Infect Dis 2004; 189(suppl 1):S185-90